Abe K,Chiba Y,Katsuse O,Takahashi Y,Suda A,Hattori S,Yoshimi R,Kirino Y,Kunii M,Yoshimi A,Asami T,Hishimoto A: Exploratory investigation on antibodies to GluN1 and cognitive dysfunction in patients with chronic autoimmune psychosis. Neuroscience Letters,743: 135588,2021.
Ban T,Kikuchi M,Go R. Sato,Manabe A,Tagata N,Harita K,Nishiyama A,Nishimura K,Yoshimi R,Kirino Y,Yanai H,Matsumoto Y,Suzuki S,Hihara H,Ito M,Tsukahara K,Yoshimatsu K,Yamamoto T,Taniguchi T,Nakajima H,Ito S,Tamura T: Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease. Nature Communications,12(1):4379,2021.
Gono T,Masui K,Nishina N,Kawaguchi Y,Kawakami A,Ikeda K,Kirino Y,Sugiyama Y,Tanino Y,Nunokawa T,Kaneko Y,Sato S,AsakawaK,Ukichi T,Kaieda S,Naniwa T,Okano Y,Kuwana M. Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis-Associated Interstitial Lung Disease. Arthritis & rheumatology (Hoboken,N.J.),73(4) 677-686,2021.
Hamada N,Maeda A,Takase-Minegishi K,Kirino Y,Sugiyama Y,Ho Namkoong,Horita N,Yoshimi R,Nakajima H; YCU irAE Working Group: Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis. Frontiers in immunology,12: 803410,2021.
Hirahara L,Kirino Y,Soejima Y,Takeno M,Takase-Minegishi K,Yoshimi R,Takeuchi M,Mizuki N,Nakajima H: Efficacy and safety of apremilast for 3 months in Behçet’s disease: A prospective observational study. Modern Rheumatology,31(4): 856-861,2021.
Ichikawa K,Kirino Y,Kunishita Y,Kishimoto D,Takase-Minegishi K,Yoshimi R,Nakajima H: Initial hydroxychloroquine monotherapy in systemic lupus erythematosus: report of three cases. Mod Rheumatol Case Rep,5(2):259-264,2021.
Iizuka Y,Takase-Minegishi K,Hirahara L,Kirino Y,Soejima Y,Ho Namkoong,Horita N,Yoshimi R,Takeuchi M,Takeno M,Mizuki N,Nakajima H. Beneficial Effects of Apremilast on Genital Ulcers,Skin Lesions,and Arthritis in Patients With Behçet’s Disease: A Systematic Review and Meta-Analysis. Modern rheumatology,2021.
Ishigami T,Nanki T,Sugawara T,Uchida K,Takeda H,Sawasaki T,Lin Chen,Doi H,Arakawa K,Saigo S,Yoshimi R,Taguri M,Kimura K,Hibi K,Wakui H,Azushima K,Tamura K: Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications,Subclinical Atherosclerosis. Methods and Protocols,4(4): 83,2021.
Kato H,Takeuchi M,Horita N,Ishido T,Mizuki R,Kawagoe T,Shibuya E,Yuda K,Ishido M,Mizuki Y,Hayashi T,Meguro A,Kirino Y,Minegishi K,Nakano H,Yoshimi R,Kurosawa M,Fukumoto T,Takeno M,Hotta K,Kaneko T,Mizuki N: HLA-A26 is a risk factor for Behçet’s disease ocular lesions. Modern Rheumatology,31(1): 214-218,2021.
Kirino Y,Takase-Minegishi K,Tsuchida N,Hirahara L,Kunishita Y,Yoshimi R,Nakajima H: Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan. Annals of the Rheumatic Diseases,80(11): 1501-1502,2021.
Kunishita Y,Yoshimi R,Kamiyama R,Kishimoto D,Komiya T,Sakurai N,Sugiyama Y,Takase-Minegishi K,Kirino Y,Nagaoka S,Nakajima H: Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus. Lupus,30(13): 2054-2065,2021.
Maruyama A,Kokuzawa A,Yamauchi Y,Kirino Y,Nagai H,Inoue Y,Ota T,Chifu Y,Inokuchi S,Koarada S,Ohta A,Iwamoto M,Tada Y. Clinical features of elderly-onset Adult-onset Still’s disease. Modern rheumatology,31(4):862-868,2021.
Maruyama A,Kokuzawa A,Yamauchi Y,Kirino Y,Nagai H,Inoue Y,Ota T,Chifu Y,Inokuchi S,Mitoma H,Akahoshi M,Sakai M,Ohta A,Iwamoto M,Tada Y. Usefulness of the Severity Classification for Predicting Drug-Free Remission in Japanese Patients With Adult-Onset Still’s Disease. Modern Rheumatology e-pub,2021.
Maruyama A,Kokuzawa A,Yamauchi Y,Kirino Y,Nagai H,Inoue Y,Ota T,Chifu Y,Inokuchi S,Koarada S,Ohta A,Iwamoto M,Tada Y. Clinical features of elderly-onset Adult-onset Still’s disease. Mod Rheumatol,31(4):862-868-,2021.
Miyawaki Y,Shimizu S,Ogawa Y,Sada K,Katayama Y,Asano Y,Hayashi K,Yamamura Y,Hiramatsu-Asano S,Ohashi K,Morishita M,Watanabe H,Takano-Narazaki M,Matsumoto Y,Yajima N,Yoshimi R,Shimojima Y,Ohno S,Kajiyama H,Ichinose K,Sato S,Fujiwara M,Yamazaki H,Yamamoto Y,Wada J,Fukuhara S: Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Research & Therapy,23(1): 79,2021.
Nagai H,Kirino Y,Nakano H,Kunishita Y,Henmi R,Ann Marie Szymanski,Yoshimi R,Michael J Ombrello,Nakajima H: Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still’s disease. Rheumatology (Oxford),60(8): 3888-3895,2021.
Nagano A,Takeuchi M,Horita N,Teshigawara T,Kawagoe T,Mizuki Y,Meguro A,Nakano H,Kirino Y,Takase-Minegishi K,Yoshimi R,Kurosawa M,Fukumoto T,Takeno M,Kaneko T,Mizuki N. Behçet’s disease and activities of daily living. Rheumatology (Oxford,England),2021.
Saito M,Yajima N,Yanai R,Tsubokura Y,Ichinose K,Yoshimi R,Ohno S,Sada K: Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study. Lupus,30(7): 1146-1153,2021.
Samukawa S,Yoshimi R,Kirino Y,Nakajima H: The PRY/SPRY domain of pyrin/TRIM20 interacts with β2-microglobulin to promote inflammasome formation. Scientific Reports,11(1): 23613,2021.
Soejima Y,Kirino Y,Takeno M,Takase-Minegishi K,Ryusuke Yoshimi R,Takeuchi M,Mizuki N,Nakajima H; Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan. Arthritis Res Ther,23(1):49,2021.
Suzuki S,Hirahara L,Oral Ulcers Associated with Scrub Typhus. Internal medicine (Tokyo,Japan), 60(23),3841–3842,2021
Tsuchida N,Kunishita Y,Uchiyama Y,Kirino Y,Enaka M,Yamaguchi Y,Taguri M,Yamanaka S,Takase-Minegishi K,Yoshimi R,Fujii S,Nakajima H,Matsumoto N. Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis. Ann Rheum Dis,80;1057-1061,2021.
Tono T,Kikuchi H,Sawada T,Takeno M,Nagafuchi H,Kirino Y,Tanaka Y,Yamaoka K,Hirohata S. Clinical Features of Behçet’s Disease Patients with Joint Symptoms in Japan: A National Multicenter Study. Modern Rheumatology e-pub,2021.
CC Zouboulis,JAM van Laar,M Schirmer,G Emmi,F Fortune,A Gül,Y Kirino,E-S Lee,P P Sfikakis,F Shahram,GR Wallace. Journal of the European Academy of Dermatology and Venereology.JEADV,35(9) e541-e543,2021.
